• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Medical Device Market
Medical Device News
Medical Device Stocks
  • Medical Device Market
  • Medical Device News
  • Medical Device Stocks
medical device investing

Alphatec Announces Commercial Launch of TLIF IdentiTi™

Written by Jocelyn Aspa
|
May. 30, 2019 09:40AM PST

Alphatec Holdings (NASDAQ:ATEC) has announced the commercial release of its IdentiTi-PC porous Titanium Interbody Implant System. As quoted in the press release: “The commercial launch of IdentiTi-PC demonstrates continued solid progress against our commitment to accelerate growth by compelling the spine market and engaging surgeons with clinical distinction,” said Pat Miles, Chairman and Chief Executive …

Alphatec Holdings (NASDAQ:ATEC) has announced the commercial release of its IdentiTi-PC porous Titanium Interbody Implant System.

As quoted in the press release:

“The commercial launch of IdentiTi-PC demonstrates continued solid progress against our commitment to accelerate growth by compelling the spine market and engaging surgeons with clinical distinction,” said Pat Miles, Chairman and Chief Executive Officer.  “This marks the fourth of twelve new product launches planned for 2019, an extraordinary level of development by any measure.  We have built the spine market’s new organic innovation machine.”

TLIF IdentiTi-PC Porous Titanium Interbody Implant System

The launch of the IdentiTi-PC Interbody Implant System follows successful alpha evaluations that began in August 2018. It marks the third of six IdentiTi implant systems the Company expects to commercially introduce in 2019.

The IdentiTi line of implant systems are manufactured using a subtractive process, which begets more predictable, proprietary porosity and results in enhanced imaging characteristics.  The implants are expected to perform better than competitive titanium implant offerings. The IdentiTi line of implants will not only complement the Company’s current suite of PEEK implants, but will also allow ATEC to address the broader market of surgeons who prefer titanium.

Click here to read the full press release.

alphatec holdings medical device investing nasdaq:atec
The Conversation (0)

Go Deeper

AI Powered
Stethoscope connected to a phone with medical data overlay.

Top 3 Small-cap Medical Device Stocks (Updated January 2026)

Phrase "top technology stocks" on blue background.

Top 5 Technology Stocks on the TSX Venture 50

Latest News

Outlook Reports world

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
  • Energy
    • Uranium
    • Oil and Gas
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Industrial Metals
  • Agriculture
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Gaming
    • Cleantech
    • Emerging Tech
Life Science
    • Biotech
    • Cannabis
    • Psychedelics
    • Pharmaceuticals

Featured Medical Device Investing Stocks

Cleo Diagnostics

Cleo Diagnostics (COV:AU)
COV:AU

Ocumetics Technology

Ocumetics Technology (OTC:CC)
OTC:CC

Bloom Health Partners

Bloom Health Partners (BLMH:CC)
BLMH:CC

Avricore Health

Avricore Health (AVCR:CC)
AVCR:CC
More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES